Publicaciones en las que colabora con MARÍA SOLEDAD FERNÁNDEZ ALFONSO (23)

2023

  1. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  3. Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats

    International Journal of Molecular Sciences, Vol. 24, Núm. 23

2022

  1. IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE

    Journal of hypertension, Vol. 40, pp. e81

2019

  1. Beneficial effect of bariatric surgery on abnormal MMP-9 and AMPK activities: Potential markers of obesity-related CV risk

    Frontiers in Physiology, Vol. 10, Núm. MAY

  2. Caloric restriction induces H2O2 formation as a trigger of AMPK-eNOS-NO pathway in obese rats: Role for CAMKII

    Free Radical Biology and Medicine, Vol. 139, pp. 35-45

  3. Impact of pharmacist’s intervention on reducing cardiovascular risk in obese patients

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 4, pp. 1099-1109

2017

  1. Mild and short-term caloric restriction prevents obesity-induced cardiomyopathy in young zucker rats without changing in metabolites and fatty acids cardiac profile

    Frontiers in Physiology, Vol. 8, Núm. FEB

  2. Rapid, automated, and specific immunoassay to directly measure matrix metalloproteinase-9-tissue inhibitor of metalloproteinase-1 interactions in human plasma using AlphaLISA technology: A new alternative to classical ELISA

    Frontiers in Immunology, Vol. 8, Núm. JUL

  3. Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

    British Journal of Pharmacology, Vol. 174, Núm. 20, pp. 3561-3572

2016

  1. Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice

    Vascular Pharmacology, Vol. 77, pp. 38-47

  2. Role of matrix metalloproteinase-9 in chronic kidney disease: A new biomarker of resistant albuminuria

    Clinical Science, Vol. 130, Núm. 7, pp. 525-538

2015

  1. High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway

    Molecular Nutrition and Food Research, Vol. 59, Núm. 3, pp. 520-532

  2. Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats

    Vascular Pharmacology, Vol. 65, pp. 3-12

  3. Vascular AMPK as an attractive target in the treatment of vascular complications of obesity

    Vascular Pharmacology, Vol. 67, pp. 10-20

2014

  1. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression

    Journal of Hypertension, Vol. 32, Núm. 10, pp. 2082-2091

  2. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat diet-derived endothelial dysfunction

    PLoS ONE, Vol. 9, Núm. 4

  3. Prolonged leptin treatment increases transient outward K+ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes

    Pflugers Archiv European Journal of Physiology, Vol. 466, Núm. 5, pp. 903-914

2013

  1. Dissecting the genetic predisposition to albuminuria and endothelial dysfunction in a genetic rat model

    Journal of Hypertension, Vol. 31, Núm. 11, pp. 2203-2212

  2. Mechanisms of perivascular adipose tissue dysfunction in obesity

    International Journal of Endocrinology, Vol. 2013